TLX-1001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTLX-1001
Drug Alias NameNEMO binding peptide (Theralogics)TLX-1001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsInhibitor of NF-kappa-B kinase (IKK) inhibitors
TargetsInhibitor of NF-kappa-B kinase (IKK)Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheralogics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheralogics Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A